April 8, 2022
Pediatric Drug Therapy 2021 | Pediatric Hyperlipidemias and Management
Pediatric Drug Therapy 2021
Pediatric Hyperlipidemias and Management
Helén Dichek, MD
Associate Professor of Pediatrics, Division of Endocrinology, University of Washington; Director, Lipid Clinic, Seattle Children’s Hospital
For pediatric nurse practitioners, family nurse practitioners, physician assistants, clinical nurse specialists, nurses, respiratory therapists, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Know the causes of hypercholesterolemia.
- Know the causes of hypertriglyceridemia.
- Know the role of weight reduction and physical activity to reduce lipids
- Know pharmacologic treatments for hyperlipidemias